FIELD: medicine.
SUBSTANCE: present group of inventions refers to medicine, namely to therapy and cardiology, and concerns lowering triglycerides without increasing LDL cholesterol in an individual receiving a concomitant statin therapy with initial fasting triglycerides 200 mg/dl to 500 mg/dl. That is ensured by administering ethyl eicosapentaenoate 4 g a day additionally.
EFFECT: invention provides lowering both total triglycerides, and low-density lipoproteins.
30 cl, 6 tbl
| Title |
Year |
Author |
Number |
| COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE |
2011 |
|
RU2606853C2 |
| COMPOSITIONS AND METHODS OF TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE |
2011 |
|
RU2728825C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING OMEGA-3 FATTY ACID AND A STATIN HYDROXY-DERIVATIVE, AND METHODS OF USING IT |
2010 |
|
RU2758369C2 |
| METHODS OF TREATING HYPERTRIGLYCERIDEMIA |
2010 |
- Manku Mekhar
- Osterlokh Jan
- Uiker P'Er
- Brakman Rene
- Soni Paresh
|
RU2505292C2 |
| METHODS OF TREATMENT OF HYPERTRIGLYCERIDEMIA |
2013 |
- Manku Mekhar
- Osterlokh Yan
- Uiker Per
- Brakman Rene
- Soni Paresh
|
RU2686315C2 |
| METHODS OF TREATMENT OF HYPERTRIGLYCERIDEMIA |
2019 |
- Manku, Mehar
- Osterloh, Ian
- Wicker, Pierre
- Braeckman, Rene
- Soni, Paresh
|
RU2797547C2 |
| COMPOSITIONS CONTAINING 15-HEPE FOR TREATING OR PREVENTING HEMATOLOGICAL DISORDERS AND/OR RELATED DISEASES |
2020 |
- Climax, John
- Hamza, Moayed
- Weissbach, Markus
- Coughlan, David
|
RU2833560C1 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING EPA AND CARDIOVASCULAR DRUG, AND METHODS OF USING THEM |
2017 |
- Manku Mekhar
- Rou Dzhonatan
|
RU2746945C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING EPA AND CARDIOVASCULAR AGENTS AND THEIR APPLICATION METHODS |
2010 |
- Manku Mekhar
- Rou Dzhonatan
|
RU2624506C2 |
| CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS |
2010 |
- Sampalis, Fotini
- Harland, Henri
|
RU2755902C2 |
